日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: results of RTOG 0215

一项随机、双盲、安慰剂对照交叉试验,研究西地那非在放射治疗和短期雄激素剥夺疗法后治疗勃起功能障碍的疗效:RTOG 0215 研究结果

Watkins Bruner, Deborah; James, Jennifer L; Bryan, Charlene J; Pisansky, Thomas M; Rotman, Marvin; Corbett, Thomas; Speight, Joycelyn; Byhardt, Roger; Sandler, Howard; Bentzen, Søren; Kachnic, Lisa; Berk, Lawrence

Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117

一项针对无法手术的非小细胞肺癌患者,采用三维适形放射治疗和同步化疗的 I/II 期剂量强化研究的 II 期部分的主要分析:RTOG 0117

Bradley, Jeffrey D; Bae, Kyounghwa; Graham, Mary V; Byhardt, Roger; Govindan, Ramaswamy; Fowler, Jack; Purdy, James A; Michalski, Jeff M; Gore, Elizabeth; Choy, Hak

A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117

一项针对无法手术的 I 至 III 期非小细胞肺癌患者的 I/II 期放射剂量递增联合化疗研究:RTOG 0117 的 I 期结果

Bradley, Jeffrey D; Moughan, Jennifer; Graham, Mary V; Byhardt, Roger; Govindan, Ramaswamy; Fowler, Jack; Purdy, James A; Michalski, Jeff M; Gore, Elizabeth; Choy, Hak

MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02

MDM2 和 Ki-67 可预测接受放射治疗和雄激素剥夺疗法治疗的前列腺癌患者的远处转移和死亡率:RTOG 92-02

Khor, Li-Yan; Bae, Kyounghwa; Paulus, Rebecca; Al-Saleem, Tahseen; Hammond, M Elizabeth; Grignon, David J; Che, Mingxin; Venkatesan, Varagur; Byhardt, Roger W; Rotman, Marvin; Hanks, Gerald E; Sandler, Howard M; Pollack, Alan